Fmr LLC Krystal Biotech, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Fmr LLC holds 4,283,766 shares of KRYS stock, worth $756 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

4,283,766

Previous 4,243,892 0.94%

Holding current value

$756 Million

Previous $755 Million 4.18%

% of portfolio

0.05%

Previous 0.05%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$153.12 - $183.64 $6.11 Million - $7.32 Million	39,874 Added 0.94%	4,283,766 $787 Million
Q1 2024 May 13, 2024	BUY	$108.01 - $179.35 $201 Million - $333 Million	1,857,994 Added 77.87%	4,243,892 $755 Million
Q4 2023 Feb 13, 2024	SELL	$96.0 - $128.29 $23.4 Million - $31.2 Million	-243,485 Reduced 9.26%	2,385,898 $296 Million
Q3 2023 Nov 13, 2023	SELL	$108.51 - $130.22 $5.67 Million - $6.8 Million	-52,214 Reduced 1.95%	2,629,383 $305 Million
Q2 2023 Aug 11, 2023	BUY	$78.48 - $130.32 $38 Million - $63.2 Million	484,639 Added 22.06%	2,681,597 $315 Million
Q1 2023 May 11, 2023	BUY	$72.39 - $84.27 $6.38 Million - $7.42 Million	88,105 Added 4.18%	2,196,958 $176 Million
Q4 2022 Feb 13, 2023	BUY	$63.14 - $79.9 $152,735 - $193,278	2,419 Added 0.11%	2,108,853 $167 Million
Q3 2022 Nov 10, 2022	BUY	$64.85 - $82.4 $11,543 - $14,667	178 Added 0.01%	2,106,434 $147 Million
Q2 2022 Aug 12, 2022	SELL	$48.93 - $73.47 $11,547 - $17,338	-236 Reduced 0.01%	2,106,256 $138 Million
Q1 2022 May 13, 2022	BUY	$51.99 - $72.11 $6.67 Million - $9.24 Million	128,203 Added 6.48%	2,106,492 $140 Million
Q4 2021 Feb 14, 2022	BUY	$39.81 - $88.24 $3.02 Million - $6.7 Million	75,884 Added 3.99%	1,978,289 $138 Million
Q3 2021 Nov 15, 2021	BUY	$52.01 - $71.77 $6.99 Million - $9.65 Million	134,488 Added 7.61%	1,902,405 $99.3 Million
Q2 2021 Aug 13, 2021	BUY	$62.14 - $81.82 $110 Million - $145 Million	1,767,917 New	1,767,917 $120 Million

Others Institutions Holding KRYS

# of Institutions

275

Shares Held

24.9M

Call Options Held

270K

Put Options Held

172K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.53B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account